Beckman Coulter grows Alzheimer’s dx portfolio with CE mark for new assay

Posted inMedical Technology

Diagnostics specialist Beckman Coulter expanded its portfolio of Alzheimer’s disease diagnostics by earning a CE mark in Europe for its Access p-Tau217 assay.